Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q2 2022 Results - Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ARWR) Q2 2022 Earnings Conference Call May 10, 2022, 04:30 PM ET Company Participants Vince Anzalone - VP, IR Christopher Anzalone - President...
Source: seekingalpha.com